Evidence map›Paper›PMID 28017807›Full record

ArticleJournal of the American College of Surgeons2017

Lymphadenectomy with Optimum of 29 Lymph Nodes Retrieved Associated with Improved Survival in Advanced Gastric Cancer: A 25,000-Patient International Database Study.

Yanghee Woo, Bryan Goldner, Philip Ituarte, Byrne Lee, Laleh Melstrom, Taeil Son, Sung Hoon Noh, Yuman Fong, Woo Jin Hyung

2 registry-linked trialsAbstract read
In one paragraph

Article in Journal of the American College of Surgeons, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 55 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 5 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04734821 narecruitingnot on this mapstarted 2021, after this paper: background citation

Prospective Study on the Contribution of Fluorescence in the Guidance of Lymphadenectomy and in Peroperative Evaluation of Pre-anastomotic Tissue Perfusion in Laparoscopic Esogastric Oncologic Resections

TypeinterventionalSponsorIHU StrasbourgRan2021 to 2026Enrolled60ConditionsEsophageal Cancer, Gastric CancerArmsNear Infra-Red Fluorescence Guided Surgery
NCT07565857 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

SIGNAL GEC-101: Signatera-Guided De-escalation of Adjuvant Therapy in Resectable Stage II-IVa Gastric/Gastric-Esophageal Cancer

TypeinterventionalSponsorNatera, Inc.Ran2026 to 2034Enrolled1,000ConditionsGastric-Esophageal CancerArmsSignatera Genome ultra-sensitive ctDNA blood test
3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 5 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Trial
  7. Trial
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Superior lymph node harvest by fluorescent lymphography during minimally invasive gastrectomy for gastric cancer patients with high body mass index.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2024
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Yanghee WooDepartment of Surgery, City of Hope National Medical Center, Duarte, CA.
Bryan GoldnerDepartment of Surgery, City of Hope National Medical Center, Duarte, CA; Department of Surgery, Kaiser Permanente, Los Angeles, CA.
Philip ItuarteDepartment of Surgery, City of Hope National Medical Center, Duarte, CA.
Byrne LeeDepartment of Surgery, City of Hope National Medical Center, Duarte, CA.
Laleh MelstromDepartment of Surgery, City of Hope National Medical Center, Duarte, CA.
Taeil SonDepartment of Surgery, Severence Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Sung Hoon NohDepartment of Surgery, Severence Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea.
Yuman FongDepartment of Surgery, City of Hope National Medical Center, Duarte, CA.
Woo Jin HyungDepartment of Surgery, Severence Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea. Electronic address: wjhyung@yuhs.ac.

Funding

Oncology Research Career Development ProgramK12CA001727 · NCI · CITY OF HOPE NATIONAL MEDICAL CENTER · PI MORTIMER, JOANNE E. · 1992 to 2024
$14.6M
NCI NIH HHS K12 CA001727
6 · The paper itself

Abstract

backgroundGastric adenocarcinoma is an aggressive disease with frequent lymph node (LN) metastases for which lymphadenectomy results in a survival benefit. In the US, the National Comprehensive Cancer Network guidelines recommend D2 lymphadenectomy or a minimum of 15 LNs retrieved. However, retrieval of only 15 LNs is considered by most international guidelines as inadequate. We sought to evaluate the survival benefits associated with a more complete lymphadenectomy. STUDY

designAn international database was constructed by combining gastric cancer cases from the Surveillance, Epidemiology, and End Results program database (n = 13,932) and the Yonsei University Gastric Cancer database (n = 11,358) (total n = 25,289). Kaplan-Meier survival analysis was performed along with Joinpoint analysis to obtain the optimal number of LNs to retrieve based on survival. Prognostic significance of number of nodes retrieved was then confirmed with univariate and multivariate analyses.

resultsAnalysis for both mean and median survival yielded 29 LNs removed as the Joinpoint. This was confirmed with multivariate analysis, where 15 retrieved LNs cutoff fell out of the model and 29 retrieved LNs remained intact, with a hazard ratio of 0.799 (95% CI 0.759 to 0.842; p < 0.001). Stage-stratified Kaplan-Meier analysis for a cutoff point of 29 LNs also demonstrated a statistically significant improvement in survival.

conclusionsJoinpoint analysis has allowed for the creation of a model demonstrating the point at which additional dissection would not provide additional benefit. This large international dataset analysis demonstrates that the maximal survival advantage is seen by performing a lymphadenectomy with a minimum of 29 LNs retrieved.

Indexed as

GastrectomyAdenocarcinomaAdolescentAdultAgedAged, 80 and overDatabases, FactualFemaleHumansKaplan-Meier EstimateLymph Node ExcisionMaleMiddle AgedMultivariate AnalysisPrognosisSEER Program

Identifiers

PMID28017807
PMCPMC5606192

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.